X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6649) 6649
Publication (474) 474
Book Review (402) 402
Conference Proceeding (17) 17
Book Chapter (16) 16
Dissertation (6) 6
Book / eBook (2) 2
Magazine Article (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5620) 5620
humans (3501) 3501
male (2613) 2613
anilides - pharmacology (2490) 2490
animals (2344) 2344
anilides - therapeutic use (1444) 1444
female (1167) 1167
anilides (1033) 1033
middle aged (903) 903
rats (875) 875
mice (856) 856
aged (825) 825
prostatic neoplasms - drug therapy (683) 683
anilides - administration & dosage (680) 680
pharmacology & pharmacy (639) 639
oncology (617) 617
anilides - chemistry (584) 584
anilides - adverse effects (569) 569
abridged index medicus (542) 542
adult (535) 535
cell line, tumor (515) 515
nitriles (511) 511
tosyl compounds (509) 509
prostate cancer (508) 508
cancer (468) 468
anilides - metabolism (437) 437
biochemistry & molecular biology (432) 432
dose-response relationship, drug (421) 421
antineoplastic agents - therapeutic use (416) 416
time factors (411) 411
chemistry, organic (408) 408
pyridines - therapeutic use (396) 396
kinetics (393) 393
androgen antagonists - therapeutic use (385) 385
prostatic neoplasms - pathology (372) 372
anilides - chemical synthesis (367) 367
urology & nephrology (353) 353
structure-activity relationship (350) 350
research (322) 322
treatment outcome (319) 319
expression (314) 314
aged, 80 and over (312) 312
chemistry (309) 309
ppar gamma - antagonists & inhibitors (300) 300
analysis (299) 299
androgen antagonists - pharmacology (295) 295
antineoplastic agents - pharmacology (295) 295
encainide (295) 295
ppar gamma - metabolism (294) 294
article (285) 285
care and treatment (279) 279
signal transduction - drug effects (279) 279
chemistry, medicinal (274) 274
activation (273) 273
pyridines - pharmacology (271) 271
chemistry, multidisciplinary (269) 269
cells, cultured (263) 263
bicalutamide (259) 259
molecular structure (255) 255
cell proliferation - drug effects (254) 254
receptors, androgen - metabolism (243) 243
anilides - pharmacokinetics (239) 239
nitriles - pharmacology (237) 237
in vitro techniques (233) 233
cell biology (226) 226
tosyl compounds - pharmacology (223) 223
prostatic neoplasms - metabolism (215) 215
carcinoma (213) 213
apoptosis (212) 212
ligands (212) 212
rats, sprague-dawley (211) 211
catalysis (208) 208
hydrogen-ion concentration (205) 205
nitriles - therapeutic use (204) 204
therapy (204) 204
drug therapy, combination (201) 201
endocrinology & metabolism (200) 200
thiazolidinediones - pharmacology (197) 197
chemical phenomena (195) 195
tosyl compounds - therapeutic use (195) 195
anilides - toxicity (193) 193
apoptosis - drug effects (191) 191
disease models, animal (190) 190
dogs (189) 189
signal transduction (188) 188
cells (183) 183
carcinoma, basal cell - drug therapy (177) 177
clinical trials as topic (177) 177
metastasis (175) 175
flutamide - pharmacology (174) 174
skin neoplasms - drug therapy (174) 174
administration, oral (173) 173
cell line (169) 169
prostate-specific antigen - blood (168) 168
stereoisomerism (168) 168
derivatives (167) 167
anti-arrhythmia agents - therapeutic use (166) 166
toxicology (164) 164
androgen receptor (162) 162
growth (162) 162
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6050) 6050
German (212) 212
Japanese (80) 80
Italian (78) 78
Russian (70) 70
French (65) 65
Chinese (32) 32
Spanish (21) 21
Polish (15) 15
Czech (14) 14
Ukrainian (9) 9
Norwegian (5) 5
Portuguese (5) 5
Danish (4) 4
Swedish (4) 4
Dutch (3) 3
Hungarian (3) 3
Slovak (3) 3
Croatian (2) 2
Finnish (2) 2
Hebrew (2) 2
Bulgarian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 5/2012, Volume 336, Issue 6082, pp. 717 - 721
Osteoarthritis (OA) is a degenerative joint disease that involves the destruction of articular cartilage and eventually leads to disability. Molecules that... 
Cartilage | Molecules | REPORTS | Chondrocytes | Collagens | Stem cells | Lead | Arthritis | Chondrogenesis | Osteoarthritis | Vehicles | PATHOGENESIS | GENE | ARTICULAR-CARTILAGE | MULTIDISCIPLINARY SCIENCES | FILAMIN | OSTEOARTHRITIS | BONE | TRANSCRIPTION FACTOR | EXPRESSION | CHONDROGENESIS | CHONDROCYTE DIFFERENTIATION | Anilides - therapeutic use | Chondrocytes - cytology | Phthalic Acids - chemistry | Humans | Anilides - chemistry | Structure-Activity Relationship | Osteoarthritis - drug therapy | Osteoarthritis - physiopathology | Chondrocytes - drug effects | Mesenchymal Stromal Cells - cytology | Cell Nucleus - metabolism | Chondrocytes - physiology | Cattle | Microfilament Proteins - metabolism | Osteoarthritis - pathology | Phthalic Acids - pharmacology | Contractile Proteins - metabolism | Chondrocytes - metabolism | Mesenchymal Stromal Cells - physiology | Core Binding Factor beta Subunit - metabolism | Disease Models, Animal | Mesenchymal Stromal Cells - drug effects | Phthalic Acids - therapeutic use | Core Binding Factor Alpha 2 Subunit - metabolism | Cartilage, Articular - cytology | Filamins | Phthalic Acids - administration & dosage | Regeneration | Animals | High-Throughput Screening Assays | Anilides - administration & dosage | Small Molecule Libraries | Anilides - pharmacology | Mice | Care and treatment | Physiological aspects | Transplantation | Methods | Molecular biology | Index Medicus | Animal models | Biomedical materials | Effectiveness | Breakdown | Biocompatibility | Articular | Adults
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2013, Volume 19, Issue 19, pp. 5505 - 5512
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2011, Volume 17, Issue 8, pp. 2502 - 2511
Journal Article
Nature Nanotechnology, ISSN 1748-3387, 04/2016, Volume 11, Issue 4, pp. 378 - 387
Journal Article
Nature, ISSN 0028-0836, 07/2016, Volume 535, Issue 7613, pp. 517 - 522
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 03/2014, Volume 57, Issue 5, pp. 2047 - 2057
Journal Article